Literature DB >> 24274635

An introduction to fast dissolving oral thin film drug delivery systems: a review.

Harsha Kathpalia1, Aasavari Gupte.   

Abstract

Many pharmaceutical companies are switching their products from tablets to fast dissolving oral thin films (OTFs). Films have all the advantages of tablets (precise dosage, easy administration) and those of liquid dosage forms (easy swallowing, rapid bioavailability). Statistics have shown that four out of five patients prefer orally disintegrating dosage forms over conventional solid oral dosages forms. Pediatric, geriatric, bedridden, emetic patients and those with Central Nervous System disorders, have difficulty in swallowing or chewing solid dosage forms. Many of these patients are non-compliant in administering solid dosage forms due to fear of choking. OTFs when placed on the tip or the floor of the tongue are instantly wet by saliva. As a result, OTFs rapidly hydrate and then disintegrate and/or dissolve to release the medication for local and/or systemic absorption. This technology provides a good platform for patent non- infringing product development and for increasing the patent life-cycle of the existing products. The application of fast dissolving oral thin films is not only limited to buccal fast dissolving system, but also expands to other applications like gastroretentive, sublingual delivery systems. This review highlights the composition including the details of various types of polymers both natural and synthetic, the different types of manufacturing techniques, packaging materials and evaluation tests for the OTFs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24274635     DOI: 10.2174/156720181006131125150249

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  15 in total

1.  Current Overview of Oral Thin Films.

Authors:  Rukiye Sevinç Özakar; Emrah Özakar
Journal:  Turk J Pharm Sci       Date:  2021-02-25

Review 2.  Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives.

Authors:  Suresh P Sulochana; Muzeeb Syed; Devaraj V Chandrasekar; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

3.  Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.

Authors:  Sana Javed; Amjad Hussain; Pervaiz Akhtar Shah; Syed Atif Raza; Ubaid Ullah Anwer; Rahat Shamim; Fatima Rasool; Muhammad Ahsan Hafiz; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2022-06-02       Impact factor: 3.246

4.  Fast-dissolving oral films containing dextromethorphan/phenylephrine for sinusitis treatment: formulation, characterization and optimization.

Authors:  Mozhgan Moonesan; Fariba Ganji; Arezoo Soroushnia; Fatemeh Bagheri
Journal:  Prog Biomater       Date:  2022-07-07

5.  Optimum topical delivery of adrenergic agonists to oral mucosa vasculature.

Authors:  Cheryl M Soref; William E Fahl
Journal:  Pharm Res       Date:  2014-07-31       Impact factor: 4.200

6.  Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers.

Authors:  Milko Radicioni; Chiara Castiglioni; Andrea Giori; Irma Cupone; Valeria Frangione; Stefano Rovati
Journal:  Drug Des Devel Ther       Date:  2017-04-11       Impact factor: 4.162

7.  Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors.

Authors:  Luca De Toni; Maurizio De Rocco Ponce; Erica Franceschinis; Stefano Dall'Acqua; Roberto Padrini; Nicola Realdon; Andrea Garolla; Carlo Foresta
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

Review 8.  Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil.

Authors:  Emmanuele A Jannini; Stéphane Droupy
Journal:  Sex Med       Date:  2018-12-03       Impact factor: 2.491

9.  Control of Drug Dissolution Rate from Film Dosage Forms Containing Valsartan.

Authors:  Yoshifumi Murata; Kyoko Kofuji; Chieko Maida
Journal:  Int Sch Res Notices       Date:  2016-05-23

10.  New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate.

Authors:  Sahar Salehi; Soheil Boddohi
Journal:  Prog Biomater       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.